Study of NGX-1998 for the Treatment of Postherpetic Neuralgia
Status:
Completed
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy, safety and tolerability of NGX-1998
applied for 5 minutes for the treatment of postherpetic neuralgia (PHN).